Pityriasis Rosea Disease

DESCRIPTION
An idiopathic self-limited skin eruption characterized by widespread papulosquamous lesions
  • System(s) affected:Skin/Exocrine
  • Genetics: Less than 5 percent of those affected give a positive family history
  • Incidence/Prevalence in USA: Relatively common but exact frequency unknown
  • Predominant age: 10-35, but occurs in all age groups
  • Predominant sex: Male = Female
SIGNS AND SYMPTOMS
  • Salmon to light brown oval plaques with fine scales centrally and "collarette" of loose scales along borders
  • Lesions average 1-2 cm in diameter and usually spare face, hands and feet in adults
  • Lesions frequently oriented along skin cleavage lines in "Christmas tree" pattern
  • Eruption often preceded by 2-6 cm "herald patch" of similar appearance days to weeks before generalized rash
  • Mild pruritus, rarely severe
  • Fever and malaise rare
  • Variant forms include purpuric, urticarial, and vesicular lesions
CAUSES
Unknown, may be a viral agent or an autoimmune disorder
RISK FACTORS
Unknown
LABORATORY

WBC normal. No specific lab markers. Serology to rule out syphilis.

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
Chronic inflammation with cytolytic degeneration of keratinocytes adjacent to Langerhans cells
SPECIAL TESTS
KOH preparation to distinguish from tinea corporis
IMAGING

N/A

DIAGNOSTIC PROCEDURES

N/A

APPROPRIATE HEALTH CARE

Outpatient

GENERAL MEASURES
  • Symptomatic treatment
  • Topical antipruritics as needed
  • Ultraviolet therapy has been used but efficacy not proven
  • Lukewarm oatmeal baths (not hot as it can intensify itching)
SURGICAL MEASURES

N/A

ACTIVITY

Full activity with good skin hygiene to prevent secondary infection

DIET

N/A

PATIENT EDUCATION
  • Reassurance as to self-limited nature of condition
  • Printed patient information available from: American Academy of Dermatology (708) 330-0230.
PREVENTION/AVOIDANCE

N/A

POSSIBLE COMPLICATIONS

Secondary infection (e.g., impetigo)

EXPECTED COURSE AND PROGNOSIS

Gradual resolution in 1-14 weeks (usually 2-6)

ASSOCIATED CONDITIONS

N/A

AGE-RELATED FACTORS

Pediatric:Face, distal extremities more often involved in children and lesions may be more papular
Geriatric: N/A
Others: N/A

PREGNANCY

N/A

OTHER NOTES

N/A

ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.